Jon D. Herrington - Concepedia

Author

Jon D. Herrington

Scott & White Memorial Hospital ORCID

Also Known As

J Herrington, J. Herrington, Jon D Herrington, Jon D. Herrington, Jon Herrington

Publications

811

Citations

H-Index

Concepts

All Affiliations

Scott & White Memorial Hospital Baylor Scott & White Medical Center - Temple Texas A&M University University of Kentucky Albert B. Chandler Hospital

About

Jon D. Herrington is an author at Scott & White Memorial Hospital specializing in medicine, hematology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	262
2	Health Sciences	2	2	46
3	Public Health	1	1	15
4	Blood Transplantation	1	1	10
5	Hepatology	1	1	17

Jon D. Herrington

Publications

677

Citations

H-Index

Page 1

	Year	Citations
Randomized, placebo‐controlled, pilot study evaluating aprepitant single dose plus palonosetron and dexamethasone for the prevention of acute and delayed chemotherapy‐induced nausea and vomiting Jon D. Herrington, Adam D. Jaskiewicz, Juhee Song Cancer	2008	79
Recurrent Peripheral Arterial Thrombosis Induced by Cisplatin and Etoposide Rita Cool, Jon D. Herrington, Lucas Wong Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2002	49
Tumor Lysis Syndrome in Solid Tumors Frank E. Mott, Alex Esana, Carl Chakmakjian, Supportive Cancer Therapy Tumoral PathologySurgical PathologyHistopathologyPathologyTumor Lysis Syndrome	2005	47
Possible cobalt toxicity in maintenance hemodialysis patients after treatment with cobaltous chloride: a study of blood and tissue cobalt concentrations in normal subjects and patients with terminal and renal failure. Curtis, Goode Gc, Jon D. Herrington, PubMed HemodialysisHeart FailurePossible Cobalt ToxicityRenal FunctionKidney Failure	1976	46
Prospective evaluation of carboplatin AUC dosing in patients with a BMI ≥27 or Cachexia Jon D. Herrington, Hai T. Tran, Mark W. Riggs Cancer Chemotherapy and Pharmacology OncologyClinical TrialsProspective EvaluationBmi ≥27Carboplatin Auc Dosing	2005	46
Darbepoetin versus epoetin Jon D. Herrington American Journal of Health-System Pharmacy	2005	40
Chemical Pleurodesis With Doxycycline 1 g Jon D. Herrington, Mary Lea Gora‐Harper, Robert K. Salley Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	1996	36
Severe Necrosis Due to Paclitaxel Extravasation Jon D. Herrington, José A. Figueroa Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	1997	35
Utilization of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia Jon D. Herrington, Stephen L. Davidson, Dianne Tomita, American Journal of Health-System Pharmacy Therapeutic Drug MonitoringDarbepoetin AlfaOncologyChemoprevention StrategyMedicine	2005	33
Lipid‐Lowering Efficacy and Safety After Switching to Atazanavir‐Ritonavir‐Based Highly Active Antiretroviral Therapy in Patients with Human Immunodeficiency Virus Sean Nguyen, Susan A. Eaton, Amy M. Bain, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2008	29

Page 1